Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing neostigmine in parenteral dose form (medicinal product form) | Is a | Product containing neostigmine (medicinal product) | true | Inferred relationship | Some | ||
| Product containing neostigmine in parenteral dose form (medicinal product form) | Has active ingredient | Neostigmine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing neostigmine in parenteral dose form (medicinal product form) | Has manufactured dose form | för injektion | false | Inferred relationship | Some | ||
| Product containing neostigmine in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing neostigmine in parenteral dose form (medicinal product form) | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| neostigminmetylsulfat 2,5 mg/ml, för injektion | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Prostigmin 2.5mg/1mL injection | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| neostigmin 2,5 mg + glykopyrron 500 mikrogram, injektionsvätska, lösning, ampull 1 ml | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| neostigminmetylsulfat 0,5 mg/ml, för injektion | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| neostigminmetylsulfat 0,25 mg/ml, för injektion | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| neostigminmetylsulfat 1 mg/ml, för injektion | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Prostigmin 2.5mg/1mL injection | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| neostigmin + glykopyrron | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| neostigmin 2,5 mg + glykopyrron 500 mikrogram, injektionsvätska, lösning, ampull 1 ml | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| glykopyrrolat 500 mikrogram/ml + neostigminmetylsulfat 2,5 mg/ml, injektionsvätska, lösning, ampull | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| neostigminmetylsulfat 2,5 mg/ml, injektionsvätska, lösning, ampull | Is a | False | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Glycopyrronium- and neostigmine-containing product in parenteral dose form | Is a | True | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing only neostigmine in parenteral dose form (medicinal product form) | Is a | True | Product containing neostigmine in parenteral dose form (medicinal product form) | Inferred relationship | Some | 
This concept is not in any reference sets